Richard Kuntz - 30 May 2023 Form 3 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role: Director
Signature: /s/ Amy Culbert, attorney-in-fact
Issuer symbol: DMAC
Transactions as of: 30 May 2023
Transactions value $: $0
Form type: 3
Filing time: 30 May 2023, 16:21:51 UTC
Previous filing: 16 May 2023
Next filing: 05 Jul 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities are beneficially owned Exhibit List - Exhibit No. 24 - Power of Attorney